Showing metabocard for Methyl_cholic-acid_L-valine (MMDBc0060647)
Microbial
Human
Co-metabolite
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 20:09:57 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:11 UTC | ||||||||||||
| Metabolite ID | MMDBc0060647 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Methyl_cholic-acid_L-valine | ||||||||||||
| Description | Methyl_cholic-acid_L-valine is a bile acid derivative that belongs to the class of amino acid conjugates. There is little literature available on this metabolite, indicating that further research may be needed to fully understand its biological significance and potential implications in health and disease. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C30H51NO6 | ||||||||||||
| Average Mass | 521.739 | ||||||||||||
| Monoisotopic Mass | 521.371638366 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | RJIHMXGIGPKEOP-AZZBHOLLSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Chromatographic Retention Times and Retention Indices | |||||||||||||
| Retention Times | Not Available | ||||||||||||
| Retention Indices | Not Available | ||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | Not Available | ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | RJIHMXGIGPKEOP-AZZBHOLLSA-N | ||||||||||||
| General References | |||||||||||||
| |||||||||||||
